Blog

The rapid success of mRNA vaccines reshaped modern immunology, demonstrating the power of nucleic acid–based platforms at global scale

Acute myeloid leukemia (AML) remains one of the most challenging hematological malignancies to treat. Venetoclax (Venclexta), a BCL-2 inhibi